SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis

BIT:SVS • IT0005469264

8.84 EUR
+0.32 (+3.76%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SVS. SVS was compared to 67 industry peers in the Health Care Equipment & Supplies industry. SVS has an average financial health and profitability rating. SVS is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year SVS was profitable.
  • In the past year SVS has reported a negative cash flow from operations.
  • SVS had positive earnings in each of the past 5 years.
  • Each year in the past 5 years SVS had a positive operating cash flow.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

  • SVS has a Return On Assets (3.75%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of 10.43%, SVS is in the better half of the industry, outperforming 68.66% of the companies in the same industry.
  • SVS has a Return On Invested Capital of 8.04%. This is in the better half of the industry: SVS outperforms 65.67% of its industry peers.
  • SVS had an Average Return On Invested Capital over the past 3 years of 6.63%. This is below the industry average of 9.66%.
  • The last Return On Invested Capital (8.04%) for SVS is above the 3 year average (6.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROIC 8.04%
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • With a Profit Margin value of 5.09%, SVS perfoms like the industry average, outperforming 49.25% of the companies in the same industry.
  • SVS's Profit Margin has improved in the last couple of years.
  • SVS has a Operating Margin (8.71%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of SVS has grown nicely.
  • SVS has a Gross Margin of 26.17%. This is amonst the worse of the industry: SVS underperforms 88.06% of its industry peers.
  • SVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SVS is creating some value.
  • SVS has less shares outstanding than it did 1 year ago.
  • SVS has less shares outstanding than it did 5 years ago.
  • SVS has a better debt/assets ratio than last year.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 1.82 indicates that SVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • SVS's Altman-Z score of 1.82 is on the low side compared to the rest of the industry. SVS is outperformed by 64.18% of its industry peers.
  • SVS has a Debt/Equity ratio of 0.62. This is a neutral value indicating SVS is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.62, SVS is not doing good in the industry: 67.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC1.13
WACC7.12%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.82 indicates that SVS should not have too much problems paying its short term obligations.
  • SVS has a Current ratio of 1.82. This is comparable to the rest of the industry: SVS outperforms 58.21% of its industry peers.
  • A Quick Ratio of 1.34 indicates that SVS should not have too much problems paying its short term obligations.
  • The Quick ratio of SVS (1.34) is better than 64.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.34
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.41%, which is quite impressive.
  • The Earnings Per Share has been growing by 19.97% on average over the past years. This is quite good.
  • The Revenue has grown by 9.07% in the past year. This is quite good.
  • The Revenue has been growing by 10.34% on average over the past years. This is quite good.
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.83% on average over the next years. This is quite good.
  • Based on estimates for the next years, SVS will show a quite strong growth in Revenue. The Revenue will grow by 9.07% on average per year.
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 6.96, which indicates a rather cheap valuation of SVS.
  • SVS's Price/Earnings ratio is rather cheap when compared to the industry. SVS is cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.27. SVS is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 5.99, which indicates a rather cheap valuation of SVS.
  • 95.52% of the companies in the same industry are more expensive than SVS, based on the Price/Forward Earnings ratio.
  • SVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.16.
Industry RankSector Rank
PE 6.96
Fwd PE 5.99
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SVS is valued cheaper than 94.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.76
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SVS's earnings are expected to grow with 14.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)0.35
EPS Next 2Y17.92%
EPS Next 3Y14.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • SVS has a Yearly Dividend Yield of 2.87%. Purely for dividend investing, there may be better candidates out there.
  • SVS's Dividend Yield is rather good when compared to the industry average which is at 1.14. SVS pays more dividend than 91.04% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, SVS pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.87%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 19.64% of the earnings are spent on dividend by SVS. This is a low number and sustainable payout ratio.
DP19.64%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
SVS.MI Dividend Payout.SVS.MI Dividend Payout, showing the Payout Ratio.SVS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SVAS BIOSANA SPA

BIT:SVS (2/16/2026, 7:00:00 PM)

8.84

+0.32 (+3.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap49.50M
Revenue(TTM)132.55M
Net Income(TTM)6.74M
Analysts80
Price Target17.44 (97.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.87%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP19.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.93%
PT rev (3m)15.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.96
Fwd PE 5.99
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 1.06
EV/EBITDA 4.76
EPS(TTM)1.27
EY14.37%
EPS(NY)1.47
Fwd EY16.68%
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS23.67
BVpS11.54
TBVpS8.36
PEG (NY)0.21
PEG (5Y)0.35
Graham Number18.16
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROCE 10.81%
ROIC 8.04%
ROICexc 10.91%
ROICexgc 14.1%
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
FCFM N/A
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
ROICexc(3y)10.45%
ROICexc(5y)9.43%
ROICexgc(3y)12.81%
ROICexgc(5y)11.57%
ROCE(3y)8.91%
ROCE(5y)8.53%
ROICexgc growth 3Y10.44%
ROICexgc growth 5Y8.61%
ROICexc growth 3Y11.05%
ROICexc growth 5Y7.72%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA 2.36
Cap/Depr 113.41%
Cap/Sales 4.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.34
Altman-Z 1.82
F-Score5
WACC7.12%
ROIC/WACC1.13
Cap/Depr(3y)111.56%
Cap/Depr(5y)102.51%
Cap/Sales(3y)5.01%
Cap/Sales(5y)4.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A
EBIT growth 1Y17.64%
EBIT growth 3Y17.79%
EBIT growth 5Y14.69%
EBIT Next Year94.24%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y-245.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.92%
OCF growth 3Y26.58%
OCF growth 5Y-3.68%

SVAS BIOSANA SPA / SVS.MI FAQ

What is the ChartMill fundamental rating of SVAS BIOSANA SPA (SVS.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SVS.MI.


Can you provide the valuation status for SVAS BIOSANA SPA?

ChartMill assigns a valuation rating of 7 / 10 to SVAS BIOSANA SPA (SVS.MI). This can be considered as Undervalued.


How profitable is SVAS BIOSANA SPA (SVS.MI) stock?

SVAS BIOSANA SPA (SVS.MI) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SVAS BIOSANA SPA (SVS.MI) stock?

The Price/Earnings (PE) ratio for SVAS BIOSANA SPA (SVS.MI) is 6.96 and the Price/Book (PB) ratio is 0.77.


Is the dividend of SVAS BIOSANA SPA sustainable?

The dividend rating of SVAS BIOSANA SPA (SVS.MI) is 6 / 10 and the dividend payout ratio is 19.64%.